| Cvs Pharmacy #05044 | |
| 9718 N Kings Hwy, Myrtle Beach, South Carolina 29572 | |
| (843) 497-8625 |
| Name | Cvs Pharmacy #05044 |
|---|---|
| Organization Name | South Carolina Cvs Pharmacy Llc. |
| Location | 9718 N Kings Hwy, Myrtle Beach, South Carolina 29572 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (843) 497-8625 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
BGI and Covaris, Inc. today announced a deal that will integrate Covaris' Adaptive Focused Acoustics AFA DNA shearing technology across several BGI laboratories in China.
Researchers have developed a new, rapid biosensor for the early detection of even tiny concentrations of the human influenza A (H1N1) virus.
Doctors may one day be able to control alcohol addiction by manipulating the molecular events in the brain that underlie anxiety associated with alcohol withdrawal, researchers at the University of Illinois at Chicago College of Medicine and the Jesse Brown VA Medical Center report in the March 5 issue of the Journal of Neuroscience.
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response rate of 33 percent of treated patients with early-stage, resectable non-small cell lung cancers, meaning these patients had less than or equal to 10 percent viable tumor remaining at surgery.
Our review included analyses of drug and device studies conducted in humans. The drugs or devices could be compared to placebo or sham treatments, or other effective treatments. The drugs and devices examined for this review are used for a wide variety of clinical conditions, including cardiovascular and psychiatric diseases.
› Verified 4 days ago
| NPI Number | 1033213848 |
| Organization Name | SOUTH CAROLINA CVS PHARMACY, L.L.C. |
| Doing Business As | CVS PHARMACY #05044 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 9718 N Kings Hwy, Myrtle Beach, SC 29572 |
| Phone Number | 843-497-8625 |
News Archive
BGI and Covaris, Inc. today announced a deal that will integrate Covaris' Adaptive Focused Acoustics AFA DNA shearing technology across several BGI laboratories in China.
Researchers have developed a new, rapid biosensor for the early detection of even tiny concentrations of the human influenza A (H1N1) virus.
Doctors may one day be able to control alcohol addiction by manipulating the molecular events in the brain that underlie anxiety associated with alcohol withdrawal, researchers at the University of Illinois at Chicago College of Medicine and the Jesse Brown VA Medical Center report in the March 5 issue of the Journal of Neuroscience.
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response rate of 33 percent of treated patients with early-stage, resectable non-small cell lung cancers, meaning these patients had less than or equal to 10 percent viable tumor remaining at surgery.
Our review included analyses of drug and device studies conducted in humans. The drugs or devices could be compared to placebo or sham treatments, or other effective treatments. The drugs and devices examined for this review are used for a wide variety of clinical conditions, including cardiovascular and psychiatric diseases.
› Verified 4 days ago
News Archive
BGI and Covaris, Inc. today announced a deal that will integrate Covaris' Adaptive Focused Acoustics AFA DNA shearing technology across several BGI laboratories in China.
Researchers have developed a new, rapid biosensor for the early detection of even tiny concentrations of the human influenza A (H1N1) virus.
Doctors may one day be able to control alcohol addiction by manipulating the molecular events in the brain that underlie anxiety associated with alcohol withdrawal, researchers at the University of Illinois at Chicago College of Medicine and the Jesse Brown VA Medical Center report in the March 5 issue of the Journal of Neuroscience.
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response rate of 33 percent of treated patients with early-stage, resectable non-small cell lung cancers, meaning these patients had less than or equal to 10 percent viable tumor remaining at surgery.
Our review included analyses of drug and device studies conducted in humans. The drugs or devices could be compared to placebo or sham treatments, or other effective treatments. The drugs and devices examined for this review are used for a wide variety of clinical conditions, including cardiovascular and psychiatric diseases.
› Verified 4 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1626 American Way, Myrtle Beach, South Carolina 29577 Phone: (843) 213-3600 | |
Coastal Cancer Center Type: Pharmacy Location: 8121 Rourk St, Myrtle Beach, South Carolina 29572 Phone: (843) 692-5000 | |
Beachside Clinic Inc. Type: Prosthetic/Orthotic Supplier Location: 931 Medical Circle, Myrtle Beach, South Carolina 29572 Phone: (843) 712-1069 | |
Carolina Orthotics And Prosthetics Type: Prosthetic/Orthotic Supplier Location: 1294 Professional Dr, Myrtle Beach, South Carolina 29577 Phone: (843) 497-9558 | |
Carolina Rehab & Physical Medicine Type: Medicare Supplier Location: 1211 48 Ave N, Myrtle Beach, South Carolina 29577 Phone: (843) 449-1000 |